NFKB1 and neoplasm: However, recent reports [29,95] showed that CCL20-CCR6 is part of a NF-κB/chemokine onco-immuno crosstalk that leads to CCR6 dependent immune cell recruitment, which in turn promotes tumor cell invasion, proliferation and resistance against cell death inducing treatments.